Northern Trust
ONCS

Northern Trust’s OncoSec Medical Incorporated ONCS Stock Holding History

Northern Trust’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,818
Closed -$20K – 4794
2022
Q3 		$20K Hold
1,818
– – ﹤0.01% 4552
2022
Q2 		$30K Hold
1,818
– – ﹤0.01% 4560
2022
Q1 		$46K Hold
1,818
– – ﹤0.01% 4550
2021
Q4 		$38K Hold
1,818
– – ﹤0.01% 4637
2021
Q3 		$85K Sell
1,818
-153
-8% -$7.75K ﹤0.01% 4441
2021
Q2 		$122K Hold
1,971
– – ﹤0.01% 4316
2021
Q1 		$207K Buy
1,971
+730
+59% +$99.9K ﹤0.01% 4109
2020
Q4 		$176K Buy
1,241
+604
+95% +$64.4K ﹤0.01% 4002
2020
Q3 		$47K Buy
637
+117
+23% +$9.12K ﹤0.01% 4113
2020
Q2 		$23K Hold
520
– – ﹤0.01% 4159
2020
Q1 		$15K Hold
520
– – ﹤0.01% 4121
2019
Q4 		$21K Hold
520
– – ﹤0.01% 4154
2019
Q3 		$23K Hold
520
– – ﹤0.01% 4144
2019
Q2 		$29K Hold
520
– – ﹤0.01% 4138
2019
Q1 		$64K Sell
520
-2
-0.4% -$273 ﹤0.01% 4005
2018
Q4 		$73K Buy
522
+131
+34% +$32.9K ﹤0.01% 3983
2018
Q3 		$120K Hold
391
– – ﹤0.01% 3995
2018
Q2 		$119K Hold
391
– – ﹤0.01% 3983
2018
Q1 		$162K Buy
391
+134
+52% +$55K ﹤0.01% 3874
2017
Q4 		$92K Buy
257
+150
+140% +$52.5K ﹤0.01% 3990
2017
Q3 		$23K Hold
107
– – ﹤0.01% 4142
2017
Q2 		$28K Hold
107
– – ﹤0.01% 4151
2017
Q1 		$30K Sell
107
-11
-9% -$3.2K ﹤0.01% 4117
2016
Q4 		$32K Buy
118
+3
+3% +$1.03K ﹤0.01% 4056
2016
Q3 		$43K Hold
115
– – ﹤0.01% 4027
2016
Q2 		$42K Buy
115
+45
+64% +$19K ﹤0.01% 4040
2016
Q1 		$39K Hold
70
– – ﹤0.01% 4056
2015
Q4 		$37K Hold
70
– – ﹤0.01% 4101
2015
Q3 		$79K Buy
+70
New +$91.8K ﹤0.01% 3993

Other funds holding ONCS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Northern Trust's ONCS Position: Q4 2022 in Review

Northern Trust sold out of OncoSec Medical Incorporated (ONCS) in Q4 2022, closing a stake of 1,818 shares — an estimated $20K sold.

Northern Trust first reported a position in ONCS in Q3 2015 and held it in 29 quarters. The position peaked at $207K in Q1 2021. 17 funds tracked by Wall St. Rank hold ONCS as of Q4 2022.

  • Northern Trust reported no remaining OncoSec Medical Incorporated position as of Q4 2022 after selling out during the quarter.
  • Northern Trust sold 1,818 OncoSec Medical Incorporated shares in Q4 2022, an estimated $20K.
  • Northern Trust first reported a position in OncoSec Medical Incorporated in Q3 2015 and held it in 29 quarters.
  • Northern Trust's OncoSec Medical Incorporated position peaked at $207K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2022.

Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.